Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000253

EVP CLO & General Counsel sold 13,441 shares at an average $69.74 ($937,338)

  • EVP CLO & General Counsel acquired 10,200 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

O'NEIL PATRICK R. · EVP CLO & General Counsel

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-10-06 Exercise or conversion : show line 1 in the form 10b5-1 +10,200 $52.87 $539,274 67,330 D
2025-10-06 Sale : show line 2 in the form 10b5-1 −10,200 $69.89 $712,849 57,130 D
2025-10-06 Sale : show line 3 in the form 10b5-1 −3,241 $69.27 $224,488 53,889 D
Open-market sales · 13,441 sh · avg $69.74 · $937,338

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-10-06 Exercise or conversion : show line 4 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −10,200 17,000 D
Loading xslF345X05/edgardoc.xml…